Hunter Gillies - Net Worth and Insider Trading
Hunter Gillies Net Worth
The estimated net worth of Hunter Gillies is at least $14,789 dollars as of 2024-11-29. Hunter Gillies is the CHIEF MEDICAL OFFICER of Aerovate Therapeutics Inc and owns about 5,602 shares of Aerovate Therapeutics Inc (AVTE) stock worth over $14,789. Details can be seen in Hunter Gillies's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Hunter Gillies has not made any transactions after 2024-06-13 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Hunter Gillies
Hunter Gillies Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Hunter Gillies owns 1 companies in total, including Aerovate Therapeutics Inc (AVTE) .
Click here to see the complete history of Hunter Gillies’s form 4 insider trades.
Insider Ownership Summary of Hunter Gillies
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| AVTE | Aerovate Therapeutics Inc | 2024-06-13 | Chief Medical Officer |
Hunter Gillies Latest Holdings Summary
Hunter Gillies currently owns a total of 1 stock. Hunter Gillies owns 5,602 shares of Aerovate Therapeutics Inc (AVTE) as of June 13, 2024, with a value of $14,789.
Latest Holdings of Hunter Gillies
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| AVTE | Aerovate Therapeutics Inc | 2024-06-13 | 5,602 | 2.64 | 14,789 |
Holding Weightings of Hunter Gillies
Hunter Gillies Form 4 Trading Tracker
According to the SEC Form 4 filings, Hunter Gillies has made a total of 15 transactions in Aerovate Therapeutics Inc (AVTE) over the past 5 years, including 0 buys and 15 sells. The most-recent trade in Aerovate Therapeutics Inc is the sale of 6,000 shares on June 13, 2024, which brought Hunter Gillies around $147,000.
Insider Trading History of Hunter Gillies
- 1
Hunter Gillies Trading Performance
Hunter Gillies Ownership Network
Hunter Gillies Owned Company Details
What does Aerovate Therapeutics Inc do?
Who are the key executives at Aerovate Therapeutics Inc?
Hunter Gillies is the Chief Medical Officer of Aerovate Therapeutics Inc. Other key executives at Aerovate Therapeutics Inc include director & 10 percent owner Ra Capital Healthcare Fund Lp , See Remarks George A Eldridge , and SENIOR VICE PRESIDENT & CMC Marinus Verwijs .
Aerovate Therapeutics Inc (AVTE) Insider Trades Summary
Over the past 18 months, Hunter Gillies made 12 insider transaction in Aerovate Therapeutics Inc (AVTE) with a net sale of 63,100. Other recent insider transactions involving Aerovate Therapeutics Inc (AVTE) include a net sale of 131,717 shares made by Benjamin T Dake , a net sale of 62,449 shares made by Timothy P Noyes , and a net sale of 32,100 shares made by Ralph Niven .
In summary, during the past 3 months, insiders sold 0 shares of Aerovate Therapeutics Inc (AVTE) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 390,394 shares of Aerovate Therapeutics Inc (AVTE) were sold and 928,110 shares were bought by its insiders, resulting in a net purchase of 537,716 shares.
Aerovate Therapeutics Inc (AVTE)'s detailed insider trading history can be found in Insider Trading Tracker table.
Aerovate Therapeutics Inc Insider Transactions
Hunter Gillies Mailing Address
Above is the net worth, insider trading, and ownership report for Hunter Gillies. You might contact Hunter Gillies via mailing address: C/o Aerovate Therapeutics, Inc., 200 Berkeley Street, Floor 18, Boston Ma 02116.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
